Collectively, our results showed that the dysregulated miR-381/SPIN1 axis greatly contributes to the initiation and progression of CRC cells by orchestrating the Wnt/β-catenin pathway, and therefore represents an actionable therapeutic target for CRC patients. The gene discussed is SPIN1; the disease is colorectal carcinoma.